Orexo AB
STO:ORX
Orexo AB
STO:ORX
Price:
29.8
SEK
5.3%
Market Cap:
kr1B
Relative Value
The Relative Value of one
ORX
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 29.8 SEK,
Orexo AB
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ORX Relative Value
HIDDEN
Multiples Across Competitors
ORX Competitors Multiples
Orexo AB Competitors
Orexo AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Orexo AB
STO:ORX
|
1B SEK | 1.9 | -5.1 | 95.1 | -9.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
991B USD | 15 | 47.5 | 32 | 34 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.2B USD | 6.1 | 21.4 | 14.9 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
279.8B CHF | 4.5 | 29.7 | 12.6 | 14.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.7B CHF | 5.3 | 21.3 | 13.2 | 16.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
220.7B GBP | 5.2 | 32.4 | 15.4 | 22.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
293B USD | 4.5 | 15.9 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.6 | 9.9 | 11.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 20 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.6B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
